QLT INC.
OUR BUSINESS IS SCIENCE. OUR PRODUCT IS LIFE.
QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.
Our research and development efforts are focused on pharmaceutical products in the fields of ophthalmology and dermatology. In addition, we utilize three unique technology platforms, photodynamic therapy, Atrigel® and punctal plugs with drugs, to create products such as Visudyne® and Eligard® and future product opportunities.
CURRENT CLINICAL TRIALS
|
|
|
|
|
|
|
Employee Login
|
|
|
|
 |
|
|
|
Annual Meeting of Shareholders
|
|
|
On Wednesday, May 14, QLT held its Annual Meeting of Shareholders in Vancouver, British Columbia. To listen to a replay of the webcast
click here.
|
|
|
Morgan Stanley Global Healthcare Unplugged Conference
|
|
|
QLT presented on Thursday, May 1, at 4:20 pm ET.
Click here to listen to the presentation.
|
|
|
2008 Proxy Materials and Annual Report
|
|
|
The Proxy Materials for the Annual Meeting of Shareholders to be held on May 14, 2008 are now available. For the 2008 Proxy Statement and Annual Report for the fiscal year ended December 31, 2007,
click here.
|
|
|
Q1 2008 Earnings Conference Call
|
|
|
QLT broadcast its Q1 2008 Earnings Conference Call on Friday, April 25.
Click here to listen to a replay of the webcast.
|
|
|
|
 |
|
|
NASDAQ
(QLTI)
N/A
·
TSX
(QLT)
N/A
|
|
|
 |
|
|
